SLOWLY building up again on the buy side. Looks like the "seller" might be done.Been hoping for a slight pullback to top up. Not sure if it will come now.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025